S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Acumen Pharmaceuticals (ABOS) Earnings Date, Estimates & Call Transcripts

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free abos Stock Alerts
$3.15
-0.01 (-0.32%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Mar. 26)
-$0.29
Consensus EPS
(Mar. 26)
-$0.29
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ABOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABOS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acumen Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.26)($0.26)($0.26)
Q2 20241($0.26)($0.26)($0.26)
Q3 20241($0.26)($0.26)($0.26)
Q4 20241($0.26)($0.26)($0.26)
FY 20244($1.04)($1.04)($1.04)

ABOS Earnings Date and Information

Acumen Pharmaceuticals last posted its quarterly earnings data on March 26th, 2024. The reported ($0.29) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.29). Acumen Pharmaceuticals has generated ($1.09) earnings per share over the last year (($1.09) diluted earnings per share). Earnings for Acumen Pharmaceuticals are expected to decrease in the coming year, from ($1.22) to ($1.47) per share. Acumen Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Acumen Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)		------- 
3/26/2024Q4 2023($0.29)($0.29)-($0.29)--
11/13/2023Q3 2023($0.31)($0.24)+$0.07($0.24)--    
8/8/2023Q2 2023($0.36)($0.28)+$0.08($0.28)--
5/9/2023Q1 2023($0.33)($0.28)+$0.05($0.28)--
3/27/2023Q4 2022($0.28)($0.32)($0.04)($0.32)--    
11/14/2022Q3 2022($0.27)($0.26)+$0.01($0.26)--
8/15/2022Q2 2022($0.24)($0.25)($0.01)($0.25)--
5/16/2022Q1 2022-($0.23)($0.23)($0.23)--
11/14/2021Q3($0.17)($0.10)+$0.07($0.10)--
8/15/2021Q2 2021($0.17)($7.91)($7.74)$126.11--    

Acumen Pharmaceuticals Earnings - Frequently Asked Questions

When is Acumen Pharmaceuticals's earnings date?

Acumen Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on ABOS's earnings history.

Did Acumen Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Acumen Pharmaceuticals (NASDAQ:ABOS) reported ($0.29) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.29). Learn more on analysts' earnings estimate vs. ABOS's actual earnings.

How much profit does Acumen Pharmaceuticals generate each year?

Acumen Pharmaceuticals (NASDAQ:ABOS) has a recorded net income of -$52.37 million. ABOS has generated -$1.09 earnings per share over the last four quarters.

What is Acumen Pharmaceuticals's EPS forecast for next year?

Acumen Pharmaceuticals's earnings are expected to decrease from ($1.22) per share to ($1.47) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ABOS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends